Divalproex Sodium Delayed-release Capsules

Divalproex Sodium Delayed-release Capsules
SPL v9
SPL
SPL Set ID b0f33792-dd96-40cc-a28e-acdcdca2f4b8
Route
ORAL
Published
Effective Date 2023-09-21
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Valproic Acid (125 mg)
Inactive Ingredients
Alcohol Ammonia Butyl Alcohol Cellulose, Microcrystalline Fd&c Blue No. 1 Ferrosoferric Oxide Gelatin Hypromelloses Isopropyl Alcohol Methacrylic Acid Potassium Hydroxide Propylene Glycol Shellac Silicon Dioxide Sodium Lauryl Sulfate Talc Titanium Dioxide Triethyl Citrate Water

Identifiers & Packaging

Pill Appearance
Imprint: ZA66;125mg Shape: capsule Color: blue Color: white Size: 22 mm Score: 1
Marketing Status
ANDA Active Since 2009-01-27

Description

NDC 65841-639-01 in bottle of 100 Capsules Divalproex sodium delayed-release capsules, USP (sprinkle) Rx only 100 capsules


Medication Information

Description

NDC 65841-639-01 in bottle of 100 Capsules Divalproex sodium delayed-release capsules, USP (sprinkle) Rx only 100 capsules

Package Label.principal Display Panel

NDC 65841-639-01 in bottle of 100 Capsules

Divalproex sodium delayed-release capsules, USP (sprinkle)

Rx only

100 capsules


Structured Label Content

Package Label.principal Display Panel (PACKAGE LABEL.PRINCIPAL DISPLAY PANEL)

NDC 65841-639-01 in bottle of 100 Capsules

Divalproex sodium delayed-release capsules, USP (sprinkle)

Rx only

100 capsules


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)